Showing results (911-920 of 4,554) with videos related to
Sort By:
Pageof 456
Journal of Gastroenterology|June 13, 2023
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitisHiroyuki Yoshida, Masahiro Shiokawa, Takeshi Kuwada, et al.Journal of Gastroenterology|February 2, 2019
Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitisMasataka Kanno, Kazunori Kawaguchi, Masao Honda, et al.Journal of Gastroenterology|January 27, 2019
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver miceAkira Doi, Hayato Hikita, Yugo Kai, et al.Journal of Gastroenterology|January 26, 2019
Liver disease in adults with severe alpha-1-antitrypsin deficiencyHanan A Tanash, Eeva PiitulainenJournal of Gastroenterology|September 25, 2020
Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Grace Lai-Hung WongJournal of Gastroenterology|December 9, 2019
High incidence of head and neck cancers after endoscopic resection for esophageal cancer in younger patientsAkira Maekawa, Ryu Ishihara, Taro Iwatsubo, et al.Journal of Gastroenterology|December 23, 2019
Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive reviewToshio Watanabe, Yasuhiro Fujiwara, Francis K L ChanJournal of Gastroenterology|January 9, 2020
Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancerYosuke Hirotsu, Masao Hada, Kenji Amemiya, et al.Journal of Gastroenterology|March 31, 2020
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunitiesMette Vesterhus, Tom Hemming KarlsenJournal of Gastroenterology|October 22, 2020
Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinomaWen-Long Yu, Guanzhen Yu, Hui Dong, et al.Pageof 456